Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

STIMBullishCorporate Developmentsnews

High materiality7/10

Neuronetics expands Greenbrook Center of Excellence, signaling TMS and SPRAVATO expansion

Jul 28, 2026, 8:38 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Significant expansion with a flagship center and REMS-certification could drive higher patient throughput and utilization of NeuroStar SPRAVATO, potentially improving mid-term revenues if referrals translate to sustained volumes; lacks immediate revenue metrics, limiting upside magnitude.

AI summary

What happened, with direct paths to the underlying reporting

Neuronetics announces the grand opening of Greenbrook's Rockville Center of Excellence, a 7,000-square-foot facility designed to scale NeuroStar TMS and SPRAVATO services and pilot new therapies. It aims to accelerate clinical innovation and expand access, potentially boosting NeuroStar adoption and Greenbrook volumes as a national interventional psychiatry hub.

Neuronetics opens Greenbrook Center of Excellence in Rockville, MD.
Rockville facility is REMS-certified and designed for high-volume NeuroStar TMS and SPRAVATO.
Center aims to accelerate clinical innovation and expand access.
Rockville site will pilot emerging therapies, including psychedelic-class options.
Grand opening announced July 28, 2026; Cory Anderson comments.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Neuronetics expands Greenbrook Center of Excellence, signaling TMS and SPRAVATO expansion

Neuronetics surge from Greenbrook TMS deal; BTIG sets $5 target

Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook